BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 18956393)

  • 1. Gd-DOTA conjugate of RGD as a potential tumor-targeting MRI contrast agent.
    Park JA; Lee JJ; Jung JC; Yu DY; Oh C; Ha S; Kim TJ; Chang Y
    Chembiochem; 2008 Nov; 9(17):2811-3. PubMed ID: 18956393
    [No Abstract]   [Full Text] [Related]  

  • 2. Improved tumor-targeting MRI contrast agents: Gd(DOTA) conjugates of a cycloalkane-based RGD peptide.
    Park JA; Lee YJ; Ko IO; Kim TJ; Chang Y; Lim SM; Kim KM; Kim JY
    Biochem Biophys Res Commun; 2014 Dec; 455(3-4):246-50. PubMed ID: 25449282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gadolinium-1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid conjugate of arabinogalactan as a potential liver-targeting magnetic resonance imaging contrast agent.
    Xiao Y; Xue R; You T; Li X; Pei F; Wang X; Lei H
    Carbohydr Res; 2014 Aug; 395():9-14. PubMed ID: 24995911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of a Gadolinium-Based Nanoparticle (AGuIX) for Contrast-Enhanced MRI of the Liver in a Rat Model of Hepatic Colorectal Cancer Metastases at 9.4 Tesla.
    Fries P; Morr D; Müller A; Lux F; Tillement O; Massmann A; Seidel R; Schäfer T; Menger MD; Schneider G; Bücker A
    Rofo; 2015 Dec; 187(12):1108-15. PubMed ID: 26361379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RGD targeted poly(L-glutamic acid)-cystamine-(Gd-DO3A) conjugate for detecting angiogenesis biomarker alpha(v) beta3 integrin with MRT, mapping.
    Ke T; Jeong EK; Wang X; Feng Y; Parker DL; Lu ZR
    Int J Nanomedicine; 2007; 2(2):191-9. PubMed ID: 17722547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo magnetic resonance imaging of mice liver tumors using a new gadolinium-based contrast agent.
    Chen SH; Kuo YT; Cheng TL; Chen CY; Chiu YY; Lai JJ; Chang CC; Jaw TS; Wang YM; Liu GC
    Kaohsiung J Med Sci; 2013 May; 29(5):246-53. PubMed ID: 23639510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gadolinium chelate with DO3A conjugated 2-(diphenylphosphoryl)-ethyldiphenylphosphonium cation as potential tumor-selective MRI contrast agent.
    Chandrasekharan P; Yong CX; Poh Z; He T; He Z; Liu S; Robins EG; Chuang KH; Yang CT
    Biomaterials; 2012 Dec; 33(36):9225-31. PubMed ID: 23026708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aggregation in amphiphilic macrocycle-substituted Gd(3+) DOTA-type chelates is affected by the regiochemistry of substitution.
    Webber BC; Cassino C; Botta M; Woods M
    Inorg Chem; 2015 Mar; 54(5):2085-7. PubMed ID: 25692481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gadolinium-Labeled Aminoglycoside and Its Potential Application as a Bacteria-Targeting Magnetic Resonance Imaging Contrast Agent.
    Zhang L; Liu Y; Zhang Q; Li T; Yang M; Yao Q; Xie X; Hu HY
    Anal Chem; 2018 Feb; 90(3):1934-1940. PubMed ID: 29293308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Magnetic resonance imaging detects a specific peptide-protein binding event.
    De León-Rodríguez LM; Ortiz A; Weiner AL; Zhang S; Kovacs Z; Kodadek T; Sherry AD
    J Am Chem Soc; 2002 Apr; 124(14):3514-5. PubMed ID: 11929234
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Upconversion nanoparticles conjugated with Gd(3+) -DOTA and RGD for targeted dual-modality imaging of brain tumor xenografts.
    Jin J; Xu Z; Zhang Y; Gu YJ; Lam MH; Wong WT
    Adv Healthc Mater; 2013 Nov; 2(11):1501-12. PubMed ID: 23630101
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and Biological Evaluation of Rhein-Based MRI Contrast Agents for in Vivo Visualization of Necrosis.
    Bian L; Gao M; Zhang D; Ji A; Su C; Duan X; Luo Q; Huang D; Feng Y; Ni Y; Yin Z; Jin Q; Zhang J
    Anal Chem; 2018 Nov; 90(22):13249-13256. PubMed ID: 30379067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liposomes with conjugates of a calix[4]arene and a Gd-DOTA derivative on the outside surface; an efficient potential contrast agent for MRI.
    Schühle DT; van Rijn P; Laurent S; Vander Elst L; Muller RN; Stuart MC; Schatz J; Peters JA
    Chem Commun (Camb); 2010 Jun; 46(24):4399-401. PubMed ID: 20467663
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MRI-visible liposome nanovehicles for potential tumor-targeted delivery of multimodal therapies.
    Ren L; Chen S; Li H; Zhang Z; Ye C; Liu M; Zhou X
    Nanoscale; 2015 Aug; 7(30):12843-50. PubMed ID: 26022345
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Imaging of Human Insulin Secreting Cells with Gd-DOTA-P88, a Paramagnetic Contrast Agent Targeting the Beta Cell Biomarker FXYD2γa.
    Demine S; Balhuizen A; Debaille V; Joosten L; Fereau M; Chilla SNM; Millard I; Scharfmann R; Egrise D; Goldman S; Marchetti P; Gotthardt M; Laurent S; Burtea C; Eizirik DL
    Molecules; 2018 Aug; 23(9):. PubMed ID: 30134599
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DOTA Functionalized Cross-Linked Small-Molecule Micelles for Theranostics Combining Magnetic Resonance Imaging and Chemotherapy.
    Feng J; Luo Q; Chen Y; Li B; Luo K; Lan J; Yu Y; Zhang S
    Bioconjug Chem; 2018 Oct; 29(10):3402-3410. PubMed ID: 30200761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hydrogels incorporating GdDOTA: towards highly efficient dual T1/T2 MRI contrast agents.
    Courant T; Roullin VG; Cadiou C; Callewaert M; Andry MC; Portefaix C; Hoeffel C; de Goltstein MC; Port M; Laurent S; Elst LV; Muller R; Molinari M; Chuburu F
    Angew Chem Int Ed Engl; 2012 Sep; 51(36):9119-22. PubMed ID: 22865621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and evaluation of a targeted nanoglobular dual-modal imaging agent for MR imaging and image-guided surgery of prostate cancer.
    Tan M; Ye Z; Lindner D; Brady-Kalnay SM; Lu ZR
    Pharm Res; 2014 Jun; 31(6):1469-76. PubMed ID: 23471641
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Physical, chemical and biological evaluations of CMD-A2-Gd-DOTA. A new paramagnetic dextran polymer.
    Corot C; Schaefer M; Beauté S; Bourrinet P; Zehaf S; Bénizé V; Sabatou M; Meyer D
    Acta Radiol Suppl; 1997; 412():91-9. PubMed ID: 9240087
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design of a Gd-DOTA-phthalocyanine conjugate combining MRI contrast imaging and photosensitization properties as a potential molecular theranostic.
    Aydın Tekdaş D; Garifullin R; Şentürk B; Zorlu Y; Gundogdu U; Atalar E; Tekinay AB; Chernonosov AA; Yerli Y; Dumoulin F; Guler MO; Ahsen V; Gürek AG
    Photochem Photobiol; 2014; 90(6):1376-86. PubMed ID: 25131633
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.